Eurofins Scientific SE/ FR0014000MR3 /
| 2024-04-19 1:17:29 PM | Chg. -0.83 | Volume | Bid1:17:57 PM | Ask1:18:03 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 59.32EUR | -1.38% | 62,971 Turnover: 2.06 mill. |
59.28Bid Size: 151 | 59.32Ask Size: 350 | 11.48 bill.EUR | 0.84% | 20.10 |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,593.5000 | 1,574.9000 | 1,829.9000 | 2,167.7000 | 2,297.4000 | ||||||
| Intangible Assets | 918.2000 | 825.1000 | 895.7000 | 919.1000 | 796 | ||||||
| Long-Term Investments | 49.2000 | 51 | 81.7000 | 83.6000 | 83.6000 | ||||||
| Fixed Assets | - | - | 7,013.3000 | 7,770.2000 | 7,822.2000 | ||||||
| Inventories | 79.3000 | 157 | 154.2000 | 145.6000 | 139 | ||||||
| Accounts Receivable | 1,001.2000 | 948.5000 | 1,051.8000 | 1,053.3000 | 1,072.8000 | ||||||
| Cash and Cash Equivalents | 297 | 912.4000 | 515.3000 | 486.6000 | 1,221.2000 | ||||||
| Current Assets | 1,604.1000 | 2,518.2000 | 2,319 | 2,313.3000 | 3,066.4000 | ||||||
| Total Assets | 7,823.1000 | 8,575.5000 | 9,332.3000 | 10,083.5000 | 10,888.6000 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 409.8000 | 542 | 627.6000 | 647.7000 | 600.2000 | ||||||
| Long-term debt | - | - | 2,500.3000 | 3,111.8000 | 3,325.6000 | ||||||
| Liabilities to Banks | 504.8000 | 288.9000 | - | - | - | ||||||
| Provisions | 124.5000 | 115.3000 | 168.5000 | 187.3000 | 152.3000 | ||||||
| Liabilities | 4,925 | 4,859.1000 | 4,655.1000 | 5,232.5000 | 5,751.2000 | ||||||
| Share Capital | 1.8000 | 1.9000 | - | - | - | ||||||
| Total Equity | 2,838.6000 | 3,690.3000 | 4,647.6000 | 4,782.1000 | 5,077.5000 | ||||||
| Minority Interests | 59.5000 | 26.1000 | 29.5000 | 68.9000 | 59.9000 | ||||||
| Total liabilities equity | 7,823.1000 | 8,575.5000 | 9,332.3000 | 10,083.5000 | 10,888.6000 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 4,562.8000 | 5,438.8000 | 6,717.7000 | 6,712.1000 | 6,514.6000 | ||||||
| Depreciation (total) | 395.9000 | 426 | 450.7000 | 476 | 522 | ||||||
| Operating Result | 366.6000 | 800.3000 | 1,258.2000 | 1,036.9000 | 841.7000 | ||||||
| Interest Income | -95.7000 | -107.7000 | -203.7000 | -134.1000 | -106 | ||||||
| Income Before Taxes | 271.5000 | 694.4000 | 1,056.6000 | 903.7000 | 736.1000 | ||||||
| Income Taxes | 76.3000 | 153.9000 | 273.6000 | 220.7000 | 168.4000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | .4000 | 4.4000 | -2.4000 | ||||||
| Net Income | 195.2000 | 540.5000 | 782.6000 | 687.4000 | 570.2000 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 677.9000 | 1,223.5000 | 1,511.4000 | 1,136.3000 | 1,017.9000 | ||||||
| Cash Flow from Investing Activities | -540.2000 | -525 | -1,021 | -855.9000 | -681.1000 | ||||||
| Cash Flow from Financing | -342.2000 | -48.6000 | -910.3000 | -311.3000 | 413.6000 | ||||||
| Decrease / Increase in Cash | -200.5000 | 616 | - | - | - | ||||||
| Employees | 43,320 | 51,516 | 57,992 | 61,379 | 61,798 | ||||||
